Fmc Corp Stock Price, News & Analysis

FMC Corporation (NYSE: FMC) has announced a strategic collaboration with Micropep Technologies to develop new micropeptide-based bioherbicides targeting herbicide-resistant weeds. This multi-year agreement aims to combine R&D capabilities to create sustainable weed control solutions for corn and soybeans. The global herbicide market exceeded $26 billion in 2021, with significant opportunities for environmentally-friendly bioherbicides. The collaboration seeks to expedite the availability of effective solutions amid growing agricultural challenges.

FMC Corporation reported third quarter 2022 revenue of $1.38 billion, up 15% year-over-year, driven by strong volume and pricing. However, GAAP net income fell 27% to $118 million, with adjusted earnings per share down 14% at $1.23. The company raised its full-year revenue outlook to $5.6-$5.8 billion, reflecting 13% growth. Adjusted EBITDA guidance was narrowed to $1.37-$1.43 billion, indicating 7% growth. Free cash flow expectations were reduced to $440-$560 million, citing inflation impacts.

FMC Corporation has appointed Dr. Bénédicte Flambard as vice president, joining the senior management Operating Committee while continuing to lead the Plant Health business. Under her leadership, the Plant Health division has significantly expanded, launching new biological products like Accudo^® and Nema-C^®, and acquiring BioPhero ApS. FMC is focusing on enhancing its position in the biologicals sector, which is a fast-growing segment of the company. Flambard will operate from FMC's European Innovation Center in Denmark.

FMC Corporation (NYSE: FMC) will release its third quarter 2022 earnings on November 1, 2022, after market close. The earnings will be accessible via PR Newswire and the company's website. A webcast conference call is scheduled for November 2, 2022, at 9:00 a.m. ET, where analysts can ask questions. The replay of the call will be available until November 23, 2022. FMC is focused on providing innovative crop protection solutions amid market challenges.

FMC Corporation (NYSE: FMC) reported a strong Q2 2022 performance with revenue reaching $1.45 billion, up 17% from Q2 2021, driven by robust market demand and effective pricing strategies. Adjusted earnings per diluted share increased 7% to $1.93, although GAAP net income fell 35% to $131 million. The company raised its full-year revenue outlook to $5.5-5.7 billion, reflecting 11% growth at the midpoint. However, costs are expected to rise significantly in Q3, impacting adjusted EBITDA forecasted at $235-255 million, a 16% decline year-over-year.

FMC Corporation (NYSE: FMC) has successfully finalized its acquisition of BioPhero ApS, a Denmark-based pheromone research and production firm. The acquisition agreement was announced on June 29, 2022, and all regulatory approvals have now been satisfied. This strategic move is expected to enhance FMC's capabilities in innovative crop protection solutions, which are crucial for addressing the needs of growers worldwide amidst changing environmental challenges.

FMC Corporation (NYSE: FMC) has declared a quarterly dividend of 53 cents per share, scheduled for payment on October 20, 2022. Shareholders on record as of the close of business on September 30, 2022 will receive this dividend. FMC is committed to providing innovative agricultural solutions to meet the needs of an expanding population while focusing on environmental sustainability. The company employs around 6,400 individuals globally and is dedicated to developing effective crop protection products.

FMC Corporation (NYSE: FMC) has announced a definitive agreement to acquire Denmark-based BioPhero ApS for approximately $200 million. This acquisition adds advanced pheromone technology to FMC's product portfolio, with expectations of generating around $1 billion in revenue from pheromone products by 2030. BioPhero's innovative fermentation process lowers production costs, expanding market accessibility beyond specialty crops. FMC aims to launch five new pheromone products within the next three to five years, reinforcing its commitment to sustainable agriculture.

FMC Corporation has introduced a new brand identity for its Plant Health business, emphasizing its growth in the biologicals sector.

This year, FMC will launch two new products: Zironar™ biofungicide/bionematicide in the U.S. and Provilar™ biofungicide in Brazil, aimed at enhancing crop protection and yield.

FMC's biologicals platform includes over 50 products, supported by substantial R&D investments. The company anticipates launching four new biopesticides globally over the next four years, reinforcing its commitment to sustainable agriculture.